Zylox-Tonbridge Medical Technology Co., Ltd. (FRA:818)
2.520
-0.100 (-3.82%)
At close: Jan 30, 2026
95.35% (1Y)
| Market Cap | 896.55M +104.4% |
| Revenue (ttm) | 106.79M +35.4% |
| Net Income | 18.14M +495.0% |
| EPS | 0.06 +495.2% |
| Shares Out | n/a |
| PE Ratio | 49.43 |
| Forward PE | 31.88 |
| Dividend | 0.01 (0.47%) |
| Ex-Dividend Date | Jun 4, 2025 |
| Volume | n/a |
| Average Volume | 66 |
| Open | 2.520 |
| Previous Close | 2.620 |
| Day's Range | 2.520 - 2.520 |
| 52-Week Range | 1.270 - 2.980 |
| Beta | n/a |
| RSI | 42.64 |
| Earnings Date | Mar 20, 2026 |